New Leadership at TFRI
Effective August 1st, 2021, Dr. Jim Woodgett, PhD, FRSC, a senior scientist based at the Lunenfeld-Tanenbaum Research Institute (LTRI) at Sinai Health will become the new President and Scientific Director of The Terry Fox Research Institute (TFRI).
Dr. Woodgett is an internationally renowned biologist at the LTRI conducting research in cell signalling and transduction pathways in cancer, diabetes and neurological diseases and was Director of the Institute for 15 years. In addition, he is an advocate for increasing public support for science and medical research and is known for his science communication and public science outreach.
Dr. Woodgett succeeds TFRI’s founding president Dr. Victor Ling, O.C., O.B.C., PhD who has led the Institute since its creation in 2007. For more, see https://www.tfri.ca/updates/news/news-item/distinguished-toronto-scientist-dr-jim-woodgett-takes-up-leadership-of-terry-fox-research-institute-on-august-1.
CCRA Responds to the Engagement Request on Federal Research Support Restructuring
On behalf of the Alliance, a group of CCRA members formulated a response to a statement ... Read More »
On behalf of the Alliance, a group of CCRA members formulated a response to a statement ... Read More »
2018 Investment in Cancer Research: Report Released
Today, CCRA released its latest report on the investment in cancer research. It reveals that $491M was invested in cancer research in 2018. Although a slight increase since 2017 (up $17M), the investment has been fairly constant over the past five years.
This year's report includes some new analyses, which quantify the cancer-... Read More »
Today, CCRA released its latest report on the investment in cancer research. It reveals that $491M was invested in cancer research in 2018. Although a slight increase since 2017 (up $17M), the investment has been fairly constant over the past five years.
This year's report includes some new analyses, which quantify the cancer-... Read More »